Dr. Tony Hunter is Director of the Cancer Center. He devotes 50% effort to his role as Director. His Duties and responsibilities include coordination, planning and development of the research activities of the Cancer Center, appointment of members, administration of the CCSG budget, assuring the scientific and fiscal stability of Center research programs, oversight of and development of shared resources, encouragement of collaborations and enhancement of scientific excellence. Dr. Hunter's qualifications and experience include more than 35 years of research on viral oncogenes, mechanisms of transformation, cell growth and cell cycle control. He has received a number of prestigious awards for his research, including the General Motors Cancer Research Foundation Mott Prize, the American Cancer Society Medal of Honor, and the AACR Landon Prixe for Basic Cancer Research. He has been an American Cancer Society Research Professor since 1993. He is the recipient of three individual research grants from the NCI and served on the Board of Scientific Councilors of the NCI from 1996-1999. He has been co-PI of the CCSG for the past five years. Dr. Hunter's qualifications and role are described in more detail in Section 6.6, Center Director.

Public Health Relevance

The research mission of the Cancer Center is to understand the fundamental aspects of biology related to cancer. Leadership from experienced and respected investigators is critical to carry out the mission of the Center.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ciolino, Henry P
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Salk Institute for Biological Studies
La Jolla
United States
Zip Code
Aslanian, Aaron; Yates 3rd, John R; Hunter, Tony (2014) Mass spectrometry-based quantification of the cellular response to methyl methanesulfonate treatment in human cells. DNA Repair (Amst) 15:29-38
Lew, Erin D; Oh, Jennifer; Burrola, Patrick G et al. (2014) Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities. Elife 3:
Chaix, Amandine; Zarrinpar, Amir; Miu, Phuong et al. (2014) Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab 20:991-1005
Xia, Yifeng; Shen, Shen; Verma, Inder M (2014) NF-?B, an active player in human cancers. Cancer Immunol Res 2:823-30
Islam, Md Soriful; Catherino, William H; Protic, Olga et al. (2014) Role of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function. J Clin Endocrinol Metab 99:E775-85
Evans, Ronald M; Mangelsdorf, David J (2014) Nuclear Receptors, RXR, and the Big Bang. Cell 157:255-66
Liu, Guang-Hui; Suzuki, Keiichiro; Li, Mo et al. (2014) Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs. Nat Commun 5:4330
Buchwalter, Abigail L; Liang, Yun; Hetzer, Martin W (2014) Nup50 is required for cell differentiation and exhibits transcription-dependent dynamics. Mol Biol Cell 25:2472-84
Hatori, Megumi; Gill, Shubhroz; Mure, Ludovic S et al. (2014) Lhx1 maintains synchrony among circadian oscillator neurons of the SCN. Elife 3:e03357
Korf, Katharina; Wodrich, Harald; Haschke, Alexander et al. (2014) The PML domain of PML-RAR? blocks senescence to promote leukemia. Proc Natl Acad Sci U S A 111:12133-8

Showing the most recent 10 out of 105 publications